埃博拉病毒GP和VP40蛋白在哺乳动物细胞中的共表达及病毒样颗粒装配

doi:DOI:10.13523/j.cb.20161210

中国生物工程杂志

2016, Vol. 36

Issue (12): 66-71 DOI: DOI:10.13523/j.cb.20161210

技术与方法

埃博拉病毒GP和VP40蛋白在哺乳动物细胞中的共表达及病毒样颗粒装配

孙鹏艳^1,2,3,4, 黎奎^1,2,3,4, 刘存宝^2,3,4, 姚宇峰^2,3,4, 褚晓杰^2,3,4, 白红妹^2,3,4, 杨旭^2,3,4, 黄惟巍^2,3,4, 孙文佳^2,3,4, 马雁冰^2,3,4

1. 昆明医科大学昆明 650500;
2. 中国医学科学院/北京协和医学院医学生物学研究所昆明 650118;
3. 云南省重大传染病疫苗研发重点实验室昆明 650118;
4. 云南省重大传染病疫苗工程技术研究中心昆明 650118

Co-expression of Ebola Virus GP and VP40 Proteins and Virus-like particles Assembly in Mammalian Cells

SUN Peng-yan^1,2,3,4, LI Kui^1,2,3,4, LIU Cun-bao^2,3,4, YAO Yu-feng^2,3,4, CHU Xiao-jie^2,3,4, BAI Hong-mei^2,3,4, YANG Xu^2,3,4, HUANG Wei-wei^2,3,4, SUN Wen-jia^2,3,4, MA Yan-bing^2,3,4

1. Kunming Medical University, Kunming 650500, China;
2. Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, China;
3. Yunnan Key Laboratory of Research and Development on Severe Infection Disease, Kunming 650118, China;
4. Yunnan Engineering Research Center of Vaccine Research and Development on Severe Infection Disease, Kunming 650118, China

全文: PDF(777 KB) HTML

摘要：

目的：制备基因重组埃博拉病毒样颗粒，为疫苗研究及埃博拉病毒特异抗原、抗体检测提供基础。方法：根据埃博拉病毒扎伊尔株的GP和VP40蛋白氨基酸序列，以哺乳动物细胞基因表达密码子偏好性进行基因优化设计；化学合成GP和VP40基因片段并分别构建于表达质粒pcDNA3.1或同时构建到具有双表达单元的质粒pBudCE4.1；重组质粒经lipofectamine2000转染293FT细胞；以Western blot检测重组蛋白GP和VP40的表达；通过电镜观察病毒样颗粒。结果：构建的重组质粒经酶切鉴定及测序分析证实构建成功；Western blot结果显示，共转染分别表达GP和VP40的两个质粒或转染共表达两个蛋白的质粒都发现GP特异反应条带产生，且大小与预期相符，此外，转染共表达质粒产生的GP蛋白表达明显强于两个质粒共转染，并同时可检测到VP40的表达；电镜观察到典型的丝状的埃博拉病毒样颗粒。结论：在293FT细胞中基因优化的埃博拉病毒GP和VP40可有效表达并装配为病毒样颗粒，为进一步研究奠定了基础。

关键词： 293FT细胞; 表达; 埃博拉病毒; 病毒样颗粒

Abstract:

Objective: To co-expression Ebola virus proteins GP and VP40 in mammalian cells and generate Ebola virus-like particles. Methods: According to amino acid sequences, the nucleotide sequences of Ebola-Zaire GP and VP40 genes were optimized based on the codon usage bias in mammalian cells. The synthesized genes were cloned into expression plasmids pcDNA3.1 or pBudCE4.1 which has two expression units, and then 293FT cells were transfected with the recombinant plasmids using lipofectamine2000. The expression of recombinant proteins was detected by Western blot, and the VLPs were observed by electron microscope. Results: Specific reactive bands recognized by anti-GP antibody were found in cells transfected with the recombinant plasmid carrying optimized GP gene. The expression of recombinant GP protein mediated by the plasmid pBudCE4.1/GP/VP40 which co-expressing GP and VP40 was significantly higher than that mediated by co-transfection with the plasmids pcDNA3.1/GP which expresses GP and pcDNA3.1/VP40 which expresses VP40. Besides, VP40 expression was detectable although the level was low. Classical Ebola virus-like particles were found under the observation with electron microscope. Conclusion: Ebola virus proteins GP and VP40 were successfully expressed and assembled into virus-like particles in 293FT cells, which laid an important foundation for further studies on the development of a vaccine or virus detection reagent.

Key words: Ebola virus Virus-like particles (VLPs) 293FT cell line Expression

收稿日期: 2016-06-21 出版日期: 2016-12-25

ZTFLH:

Q819

通讯作者: 马雁冰 E-mail: may@imbcans.com.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

孙鹏艳, 黎奎, 刘存宝, 姚宇峰, 褚晓杰, 白红妹, 杨旭, 黄惟巍, 孙文佳, 马雁冰. 埃博拉病毒GP和VP40蛋白在哺乳动物细胞中的共表达及病毒样颗粒装配[J]. 中国生物工程杂志, 2016, 36(12): 66-71.

SUN Peng-yan, LI Kui, LIU Cun-bao, YAO Yu-feng, CHU Xiao-jie, BAI Hong-mei, YANG Xu, HUANG Wei-wei, SUN Wen-jia, MA Yan-bing. Co-expression of Ebola Virus GP and VP40 Proteins and Virus-like particles Assembly in Mammalian Cells. China Biotechnology, 2016, 36(12): 66-71.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/DOI:10.13523/j.cb.20161210 或 https://manu60.magtech.com.cn/biotech/CN/Y2016/V36/I12/66

[1] Hoenen T, Groseth A, Feldmann H.Current Ebola vaccines.Expert Opin Biol Ther,2012,12(7):859-872.
[2] Warfield K L, Bosio C M, Welcher B C, et al.Ebola virus-like particles protect from lethal Ebola virus infection.Proc Natl Acad Sci U S A,2003,100(26):15889-15894.
[3] Marzi A, Feldmann H.Ebola virus vaccines:an overview of current approaches.Expert Rev Vaccines,2014,13(4):521-531.
[4] Bavari S, Bosio C M, Wiegand E, et al.Lipid raft microdomains:a gateway for compartmentalized trafficking of Ebola and Marburg viruses.J Exp Med,2002,195(5):593-602.
[5] Gunther S, Feldmann H, Geisbert T W, et al.Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.J Infect Dis,2011,204(Suppl 3):S785-S790.
[6] Stahelin R V.Membrane binding and bending in Ebola VP40 assembly and egress.Front Microbiol,2014,5:300.
[7] Feldmann H, Volchkov V E, Volchkova V A, et al.Biosynthesis and role of filoviral glycoproteins.J Gen Virol,2001,82(Pt 12):2839-2848.
[8] Sobarzo A, Perelman E, Groseth A, et al.Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.Clin Vaccine Immunol,2012,19(11):1844-1852.
[9] Shahhosseini S, Das D, Qiu X, et al.Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.J Virol Methods,2007,143(1):29-37.
[10] Dhama K, Malik Y S, Malik S V, et al.Ebola from emergence to epidemic:the virus and the disease, global preparedness and perspectives.J Infect Dev Ctries,2015,9(5):441-455.
[11] Warfield K L, Aman M J.Advances in virus-like particle vaccines for filoviruses.J Infect Dis,2011,204(Suppl 3):S1053-S1059.
[12] Warfield K L, Swenson D L, Olinger G G, et al.Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.J Infect Dis,2007,196(Suppl 2):S430-S437.
[13] Johnson R F, Bell P, Harty R N.Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology.Virol J,2006,3:31.
[14] Swenson D L, Warfield K L, Kuehl K, et al.Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.FEMS Immunol Med Microbiol,2004,40(1):27-31.
[15] Warfield K L, Posten N A, Swenson D L, et al.Filovirus-like particles produced in insect cells:immunogenicity and protection in rodents.J Infect Dis,2007,196(Suppl 2):S421-S429.
[16] Kallstrom G, Warfield K L, Swenson D L, et al.Analysis of Ebola virus and VLP release using an immunocapture assay.J Virol Methods,2005,127(1):1-9.

[1]	贺立恒,张毅,张洁,任豫超,解红娥,唐锐敏,贾小云,武宗信. 基于转录组和WGCNA的甘薯花青素合成相关基因共表达网络的构建及核心基因的挖掘^*[J]. 中国生物工程杂志, 2021, 41(9): 27-36.
[2]	乔圣泰,王曼琦,徐慧妮. 番茄SlTpx原核表达蛋白的体外功能分析^*[J]. 中国生物工程杂志, 2021, 41(8): 25-32.
[3]	陈修月,周文锋,何庆,苏冰,邹亚文. 噬菌体Qβ病毒样颗粒的制备、纯化及鉴定[J]. 中国生物工程杂志, 2021, 41(7): 42-49.
[4]	李冰,张传波,宋凯,卢文玉. 生物合成稀有人参皂苷的研究进展^*[J]. 中国生物工程杂志, 2021, 41(6): 71-88.
[5]	张磊,唐永凯,李红霞,李建林,徐逾鑫,李迎宾,俞菊华. 促进原核表达蛋白可溶性的研究进展 ^*[J]. 中国生物工程杂志, 2021, 41(2/3): 138-149.
[6]	刘美琴,高博,焦月盈,李玮,虞结梅,彭向雷,郑妍鹏,付远辉,何金生. 人呼吸道合胞病毒感染的A549细胞中长链非编码RNA表达谱研究[J]. 中国生物工程杂志, 2021, 41(2/3): 7-13.
[7]	王惠临,周凯强,朱红雨,王力景,杨仲璠,徐明波,曹荣月. 凝血因子VII及其重组表达新进展[J]. 中国生物工程杂志, 2021, 41(2/3): 129-137.
[8]	杨茜,栾雨时. sly-miR399在番茄抗晚疫病中的初步探究^*[J]. 中国生物工程杂志, 2021, 41(11): 23-31.
[9]	陈素芳,夏明印,曾丽艳,安晓琴,田敏芳,彭建. 抗菌肽Cec4a的重组表达和抗菌活性研究^*[J]. 中国生物工程杂志, 2021, 41(10): 12-18.
[10]	石鹏程, 纪晓俊. 酵母系统表达人表皮生长因子研究进展 ^*[J]. 中国生物工程杂志, 2021, 41(1): 72-79.
[11]	饶海密,梁冬梅,李伟国,乔建军,财音青格乐. 真菌芳香聚酮化合物的合成生物学研究进展^*[J]. 中国生物工程杂志, 2020, 40(9): 52-61.
[12]	邓通,周海胜,吴坚平,杨立荣. 基于分子伴侣策略提高NADPH依赖型醇脱氢酶的异源可溶性表达 ^*[J]. 中国生物工程杂志, 2020, 40(8): 24-32.
[13]	张潇航,李媛媛,贾敏晅,顾奇. 弹性蛋白样生物材料的制备及性质鉴定 ^*[J]. 中国生物工程杂志, 2020, 40(8): 33-40.
[14]	吕一凡,李更东,薛楠,吕国梁,时邵辉,王春生. **LbCpf1基因的原核表达、纯化与体外切割检测 ^***[J]. 中国生物工程杂志, 2020, 40(8): 41-48.
[15]	蒋丹丹,王云龙,李玉林,张怡青. 含RGD修饰的病毒样颗粒递送ICG靶向肿瘤的研究 ^*[J]. 中国生物工程杂志, 2020, 40(7): 22-29.

Viewed

Full text

Abstract

Cited

Shared

Discussed